Ignite Creation Date:
2025-12-25 @ 5:02 AM
Ignite Modification Date:
2025-12-26 @ 4:03 AM
Study NCT ID:
NCT00630318
Status:
TERMINATED
Last Update Posted:
2017-01-12
First Post:
2008-02-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Testing New Method of Analyzing MR Images
Sponsor:
Indiana University
Organization:
Study Overview
Official Title:
Imaging Protocol Design for Anti-Angiogenesis Tracking With MRI
Status:
TERMINATED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Unable to accrue enough subjects to analyze data.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Preliminary imaging study to test for future use of this MRI-imaging for evaluating anti-angiogenesis treatment.
Detailed Description:
The purpose of this study is to develop and evaluate new MR imaging techniques and protocols for non-invasive monitoring of anti-angiogenesis treatment of breast cancer. This feasibility study is a preliminary imaging study to test this imaging protocol on subjects already undergoing MR for clinical purposes.
The specific objective of this research study is to develop and validate both MRI and functional MRI data acquisition methods, task paradigms, and post-processing techniques to ensure reliability of results.
The information derived from this research is intended to be applied to a future study of subjects undergoing experimental anti-angiogenesis drug therapy.
The specific objective of this research study is to develop and validate both MRI and functional MRI data acquisition methods, task paradigms, and post-processing techniques to ensure reliability of results.
The information derived from this research is intended to be applied to a future study of subjects undergoing experimental anti-angiogenesis drug therapy.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: